Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Toward a Pill to Enable… >

Toward a Pill to Enable Celiac Patients to Eat Foods Containing Gluten

Published: December 19, 2012.
Released by American Chemical Society  

Scientists are reporting an advance toward development of a pill that could become celiac disease's counterpart to the lactase pills that people with lactose intolerance can take to eat dairy products without risking digestive upsets. They describe the approach, which involves an enzyme that breaks down the gluten that causes celiac symptoms, in the Journal of the American Chemical Society.

Justin Siegel, Ingrid Swanson Pultz and colleagues explain that celiac disease is an autoimmune disorder in which the gluten in wheat, rye or barley products causes inflammation in the digestive tract. Enzymes in the stomach break down gluten into smaller pieces, called peptides. For most people, these peptides are harmless. But for the 2 million-3 million Americans with celiac disease, the peptides trigger an autoimmune response and painful symptoms. Currently, the only treatment is a gluten-free diet. However, the scientists reasoned that if an enzyme could further break down the offending peptides in the stomach, celiac patients might be able to eat gluten-containing foods.

They describe discovery of a naturally occurring enzyme that has some of the ideal properties for doing so. The scientists modified the enzyme in the laboratory so that it would meet all the necessary criteria. The new enzyme (called KumaMax) broke down more than 95 percent of a gluten peptide implicated in celiac disease in acidic conditions like those in the stomach. "These combined properties make the engineered [enzyme] a promising candidate as an oral therapeutic for celiac disease," say the researchers.




The above story is based on materials provided by American Chemical Society.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

People 
2/23/15 
Small Molecule Might Help Reduce Cancer in At-risk Population, Stanford Study Finds
Researchers at the Stanford University School of Medicine have found that by changing the selectivity of an enzyme, a …
Molecules 
12/4/14 
Reducing Drug Allergies Without Compromising Efficacy
An enzyme that usually triggers strong allergic reactions now circulates in the veins of a group of mice without …
Prevent 
1/13/11 

Enzyme Inhibition Or Removal May Prevent Or Treat Ischemic Retinopathy
Enzyme 
6/13/12 
Researchers Design New Substances That Might Help Fight Alzheimer's And Parkinson's Disease
This enzyme is also involved in other conditions as inflammatory bowel disease or rheumatoid arthritis, as well as in …
Small 
9/30/10 
Catalyst Sandwich
Northwestern University researchers have taken another step towards realizing a new class of polymerase chain reaction (PCR) enzyme mimics, …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile